approval
saveZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
community read0 votes
Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalJan 16, 2026 · 259d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalOct 12, 2022 · 1451d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalOct 12, 2022 · 1451d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalApr 23, 2021 · 1988d ago
comments(0)
5-min edit window · permanent after that